Skip to main content
Premium Trial:

Request an Annual Quote

Who's Paying For This?

Comparative effectiveness research is necessary so physicians, researchers, and patients, know how different drugs stack up against each other, says Forbes' Avik Roy on The Apothecary blog. While the private sector spends billions of dollars a year on such research, Roy says that NIH also has a role to play in funding. For certain types of studies that pit two companies' drugs against each other, it is necessary to get another source of funding as either company would be reluctant to pay for a trial that might end up damaging its drug's reputation. So who should pay for this research? That's the big question, Roy adds.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.